Scout Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $23.5M | Buy |
203,501
+13,631
| +7% | +$1.57M | 0.62% | 61 |
|
|
2024
Q2 | $26.1M | Buy |
189,870
+83,345
| +78% | +$11.5M | 0.7% | 44 |
|
|
2024
Q1 | $15.1M | Sell |
106,525
-155,093
| -59% | -$21.9M | 0.37% | 101 |
|
|
2023
Q4 | $34.5M | Sell |
261,618
-104,199
| -28% | -$13.7M | 0.86% | 29 |
|
|
2023
Q3 | $40.9M | Buy |
365,817
+13,870
| +4% | +$1.55M | 0.94% | 21 |
|
|
2023
Q2 | $35.3M | Buy |
351,947
+221,618
| +170% | +$22.2M | 0.72% | 36 |
|
|
2023
Q1 | $13.2M | Sell |
130,329
-28,810
| -18% | -$2.92M | 0.27% | 120 |
|
|
2022
Q4 | $19M | Sell |
159,139
-73,785
| -32% | -$8.81M | 0.39% | 86 |
|
|
2022
Q3 | $24.7M | Sell |
232,924
-8,697
| -4% | -$924K | 0.51% | 72 |
|
|
2022
Q2 | $23.6M | Hold |
241,621
| – | – | 0.47% | 79 |
|
|
2022
Q1 | $22.7M | Sell |
241,621
-7,534
| -3% | -$706K | 0.36% | 91 |
|
|
2021
Q4 | $21.2M | Sell |
249,155
-5,559
| -2% | -$473K | 0.31% | 110 |
|
|
2021
Q3 | $24.4M | Sell |
254,714
-3,904
| -2% | -$374K | 0.36% | 104 |
|
|
2021
Q2 | $25.2M | Buy |
258,618
+56,228
| +28% | +$5.47M | 0.37% | 97 |
|
|
2021
Q1 | $19.7M | Sell |
202,390
-30,445
| -13% | -$2.96M | 0.3% | 127 |
|
|
2020
Q4 | $22.3M | Sell |
232,835
-1,945
| -0.8% | -$186K | 0.41% | 90 |
|
|
2020
Q3 | $22.6M | Buy |
234,780
+61,059
| +35% | +$5.87M | 0.5% | 63 |
|
|
2020
Q2 | $21.2M | Buy |
+173,721
| New | +$21.2M | 0.51% | 66 |
|